J. L. Bainbridge & Co. Inc. Makes New Investment in Agilent Technologies, Inc. $A

J. L. Bainbridge & Co. Inc. acquired a new stake in Agilent Technologies, Inc. (NYSE:A) in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 27,150 shares of the medical research company’s stock, valued at approximately $3,606,000. Agilent Technologies comprises approximately 0.3% of J. L. Bainbridge & Co. Inc.’s investment portfolio, making the stock its 27th biggest position.

A number of other institutional investors have also recently made changes to their positions in A. Fiduciary Trust Co increased its stake in shares of Agilent Technologies by 1.6% in the third quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock worth $633,000 after buying an additional 77 shares during the period. Freestone Capital Holdings LLC boosted its position in Agilent Technologies by 2.0% during the 4th quarter. Freestone Capital Holdings LLC now owns 4,218 shares of the medical research company’s stock valued at $574,000 after buying an additional 84 shares during the period. Sapient Capital LLC boosted its position in Agilent Technologies by 4.2% during the 1st quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company’s stock valued at $240,000 after buying an additional 85 shares during the period. Plan A Wealth LLC grew its holdings in Agilent Technologies by 3.2% in the 4th quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company’s stock worth $403,000 after acquiring an additional 92 shares during the last quarter. Finally, IHT Wealth Management LLC grew its holdings in Agilent Technologies by 4.9% in the 4th quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company’s stock worth $278,000 after acquiring an additional 96 shares during the last quarter.

Agilent Technologies Trading Up 0.7%

NYSE:A opened at $149.33 on Friday. The company has a 50-day moving average price of $135.12 and a 200-day moving average price of $125.40. The stock has a market cap of $42.18 billion, a price-to-earnings ratio of 29.99, a P/E/G ratio of 2.62 and a beta of 1.25. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $160.27.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company had revenue of $1.83 billion for the quarter, compared to analysts’ expectations of $1.80 billion. During the same quarter in the previous year, the company earned $1.31 earnings per share. Agilent Technologies’s quarterly revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities analysts predict that Agilent Technologies, Inc. will post 6.03 EPS for the current year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were given a $0.255 dividend. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio is currently 20.48%.

Analysts Set New Price Targets

Several equities analysts have recently commented on A shares. Jefferies Financial Group started coverage on shares of Agilent Technologies in a research note on Thursday, July 9th. They set a “hold” rating and a $135.00 price objective for the company. Weiss Ratings upgraded Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Sunday, August 2nd. HSBC lowered their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Finally, Wolfe Research reiterated a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $160.24.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.